Category: Surrogate markers

1 9/14/2015

Dr. Richard Lehman: Why does having abnormal glucose tests cost the USA $245bn?

6 9/11/2015

Idolatry of the surrogate: Overdiagnosis in diabetes – podcast with Dr. John S. Yudkin

2 6/10/2015

LDL – Lion King of Surrogate Endpoints – key cholesterol issue this week

2 12/22/2014

Monday health news roundup: mostly gems, one dud


USA Today story shows lack of awareness of debate over pre-diabetes classification


Niacin news provides another example of how surrogate outcomes don’t tell whole story

8 7/10/2013

Some skeptical views of NYT front page “race for cholesterol drug” story

2 12/21/2012

Story of Tredaptive “good cholesterol drug” another lesson on surrogate endpoints

4 12/6/2012

Shooting down the Star’s story on breakthrough breast cancer drug


The alcohol-osteoporosis news: just 40 women…only a surrogate marker